Lutetium (¹⁷⁷Lu) chloride

Lutetium (177Lu) chloride
Clinical data
Trade names	Lumark, EndolucinBeta, Illuzyce
AHFS/Drugs.com	Lumark UK Drug Information; EndolucinBeta UK Drug Information
Pregnancy; category	AU: X (High risk); ;
ATC code	None;
Legal status
Legal status	AU: Unscheduled; EU: Rx-only; In general: ℞ (Prescription only);
Identifiers
	IUPAC name (177Lu)lutetium(3+) trichloride;
CAS Number	16434-14-3;
PubChem CID	71587001;
DrugBank	DBSALT002634;
ChemSpider	32700269;
UNII	1U477369SN;
KEGG	D10828;
CompTox Dashboard (EPA)	DTXSID20167745 ;
Chemical and physical data
Formula	Cl3Lu
Molar mass	281.32 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [Cl-].[Cl-].[Cl-].[177Lu+3];
	InChI InChI=1S/3ClH.Lu/h3*1H;/q;;;+3/p-3/i;;;1+2; Key:AEDROEGYZIARPU-SUNKFXMWSA-K;

Lutetium (¹⁷⁷Lu) chloride is a radioactive compound used for the radiolabeling of pharmaceutical molecules, aimed either as an anti-cancer therapy or for scintigraphy (medical imaging). It is an isotopomer of lutetium(III) chloride containing the radioisotope ¹⁷⁷Lu, which beta decays with a half-life of 6.64 days.